Genomic Programming of Human Neonatal Dendritic Cells in Congenital Systemic and In Vitro Cytomegalovirus Infection

Widad Dantoft1, Pablo Martínez-Vicente1,2, James Jafali1

  • 1Division of Infection and Pathway Medicine, School of Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom.

Frontiers in Immunology
|October 11, 2017
PubMed

Insights

Neonatal dendritic cells exhibit robust programming against human cytomegalovirus (HCMV) infection, with subtle temporal differences compared to adults. This suggests a set-point control mechanism, not immaturity, underlies infant resilience to viral infections.

Area of Science:

  • Immunology
  • Virology
  • Neonatal Research

Background:

  • Neonates, especially premature infants, are highly susceptible to infections.
  • The role of the neonatal immune system in viral infections is not fully understood.
  • Human cytomegalovirus (HCMV) is a common congenital infection.

Purpose of the Study:

  • To investigate the host protective responses and pathway biology of neonatal immune cells during HCMV infection.
  • To compare the immune response of neonatal and adult dendritic cells to HCMV.
  • To identify novel host factors involved in neonatal antiviral defense.

Main Methods:

  • Unbiased systems analyses of transcriptomic data from neonatal HCMV infection.
  • In vitro analysis of transcriptional programming in neonatal dendritic cells upon HCMV exposure.
  • Functional siRNA screening of G-protein coupled receptors (GPCRs) for antiviral and proviral roles.

Main Results:

  • Neonatal HCMV infection involves a focused IFN regulatory response associated with dendritic cells.
  • Neonatal dendritic cells show early IFN-chemokine responses and later plasticity in cell-cycle and lipid metabolism pathways.
  • Novel GPCR-dependent antiviral and proviral factors were identified, and neonatal dendritic cell responses were comparable to adult cells, with only subtle temporal delays.

Conclusions:

  • Neonatal dendritic cells demonstrate robust and plastic programming against HCMV, challenging the notion of immune immaturity.
  • A set-point control mechanism, rather than immaturity, likely explains neonatal susceptibility and resilience to infection.
  • Subtle quantitative and temporal differences in neonatal immune responses may contribute to variability in host defense.